Using Genomic Data for Personalised Care Melbourne Microcert (MMC)
Extend your understanding of genomic data and learn to develop effective precision treatment strategies for cancer patients.
What you will learn
Advances in genomic medicine mean oncologists can now develop personalised precision treatment strategies for cancer patients.
This Melbourne MicroCert is ideal for health professionals, researchers and other professionals in the oncology sector seeking the practical knowledge to interpret the genomic data reports that are essential to personalised cancer care.
Delivered in partnership with the VCCC Alliance, this course gives you access to leading oncological experts who'll provide evidence-based insights and indispensable guidance on using genomic data to enhance treatment plans.
Explore essential components of genomic data
Gain a solid understanding of the key components used to interpret genomic data. Examine genomic mutations specific to cancer patients, explore genome sequencing methodology, and learn about new techniques for collecting and storing genomic samples.
Analyse and interpret real-life genomic reports
Explore actual genomic reports and gain valuable practical skills to confidently interpret a cancer patient's genomic data before using your new knowledge to develop precision treatment strategies.
Understand new technologies in genomic medicine
You will review contemporary case studies and be introduced to the latest advances in genomic technologies and clinical applications. Discover how these breakthroughs are helping prevent, diagnose, and treat disease.
Apply your knowledge to a patient case study
Gain feedback from oncological experts and build on your understanding of genomic data. You'll develop a detailed report that outlines your recommendations for personalised care based on a patient's genomic profile. The practical experience you gain will be immediately applicable to your professional context.
Dr Kortnye Smith
Dr Kortnye Smith is a medical oncologist and researcher at Peter MacCallum Cancer Centre and Eastern Health. After completing her medical oncology training, she pursued a two-year fellowship at Peter MacCallum Cancer Centre and the Melbourne Genomic Health Alliance where she investigated genomic sequencing in cancer therapy. Kortyne works mainly in lung cancer and melanoma as well as focusing on her passion to improve patient equity by coordinating the Oncology in the Home program in Melbourne.
Dr Richard Rebello
Richard Rebello is a Postdoctoral Researcher at the University of Melbourne Centre for Cancer Research. He is also the Project Manager for Australia’s largest clinical genomics study (SUPER-NEXT) which focuses on resolving tissue of origin for Cancer of Unknown Primary (CUP) using of Whole Genome Sequencing (WGS).
Resource details
This course is brought to you by
